The study is designed to investigate the safety and efficacy of dutasteride capsules 0.5 mg
collected from the required number of Japanese subjects with benign prostatic hyperplasia
(BPH) in order to identify concerns or problems, if any, about the efficacy and safety of its
use at post-marketing clinical settings.